SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-059444
Filing Date
2013-11-07
Accepted
2013-11-07 09:42:42
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v358180_10q.htm 10-Q 851379
2 EX-31.1 v358180_ex31-1.htm EX-31.1 11781
3 EX-31.2 v358180_ex31-2.htm EX-31.2 11727
4 EX-32.1 v358180_ex32-1.htm EX-32.1 7834
5 EX-32.2 v358180_ex32-2.htm EX-32.2 7799
  Complete submission text file 0001144204-13-059444.txt   2678997

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rprx-20130930.xml EX-101.INS 226468
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rprx-20130930_cal.xml EX-101.CAL 34758
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rprx-20130930_def.xml EX-101.DEF 121289
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20130930_lab.xml EX-101.LAB 175348
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20130930_pre.xml EX-101.PRE 142814
11 XBRL TAXONOMY EXTENSION SCHEMA rprx-20130930.xsd EX-101.SCH 25742
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Filer) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15281 | Film No.: 131198816
SIC: 2836 Biological Products, (No Diagnostic Substances)